MedPath

clinical evaluation of Parangichakkai chooranam (internal) and Karappan ennai(external)in the treatment of Balakarappan(Atopic dermatitis) in children.

Phase 2
Completed
Conditions
Atopic dermatitis, unspecified,
Registration Number
CTRI/2019/05/019123
Lead Sponsor
Ayothidoss pandithar hospital
Brief Summary

IT Is a single non randomized open -label trial to determine the efficacy of PARANGICHAKKAI CHOORANAM (internal medicine) with KARAPPAN ENNAI (external medicine) in patients with BALAKARAPPAN(Atopic dermatitis). In the trial 30 Atopic dermatitis patients will be recruited and the trial drug parangichakkai chooranam , 5 to 6 years -1.3gm and 7 to 12 years -2gm, will be administrated orally after food twice a day and karappan ennai ( required quantity) will be applied for affected skin for a periods of 45 days.During the study period all the study related data will be recorded and documented in separate trial master file for each and every patients.During the trial period if the patient develop any adverse effect he/she will be immediately referred to the chairman, pharmaco- vigilance committee, NIS. If it will be mild event , the patient will be treated in OPD-NIS. If thr event will be reserve , the patient will be reffered to nearby Government Hospital and investigator will be take over the patient,until he/she will get recovery. the treatment will be provided with free of cost. the entire trial will be monitored by the research monitoring committee of NIS. After completion of the trial all the study related data will be analysed statistically. The outcome of this trial will be published in Indian journal of Medicial research.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria

children of both sexes in the age group of 5 to 12 years with symptoms of: 1.Erythema 2.Edema 3.Oozing 4.Itching 5.Crusting and Scaling 6.Lichenified plaque.

Exclusion Criteria

1.Scabies 2.photodermatitis 3.Fungal and parasitic skin infection 4.Psoriasis 5.Any other serious illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to evaluate the efficacy of Parangichakkai chooranam (Internal) and Karappan ennai(external)in the treatment of Balakarappan(Atopic dermatitis) using EASI Score1 to 45 days
Secondary Outcome Measures
NameTimeMethod
to standardize the physico chemical properties of the trial drugs.To study the effect of trial drug in reducing the frequency of incidence ofBalakarappan

Trial Locations

Locations (1)

Ayothidoss pandithar hospital

🇮🇳

Kancheepuram, TAMIL NADU, India

Ayothidoss pandithar hospital
🇮🇳Kancheepuram, TAMIL NADU, India
drskalaivani
Principal investigator
9790146119
drkalaivanibsms@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.